Literature DB >> 12453927

Plasma lidocaine concentrations following insertion of 2% lidocaine gel into the uterine cavity after uterine balloon thermal ablation.

G F Rousseau1, M Oram, J Barrington, M Priston, M Swart.   

Abstract

BACKGROUND: Uterine balloon thermal ablation is used to treat menorrhagia. We thought that intrauterine application of 2% lidocaine gel could reduce postoperative pain after this procedure. Before using this technique we wished to establish how much lidocaine is absorbed systemically from the uterine cavity after thermal ablation.
METHODS: Ten ASA I-II patients (age 38-50 yr) underwent uterine balloon thermal ablation under general anaesthesia. They each had 11 ml of 2% lidocaine gel (Instillagel(TM)) inserted into the uterine cavity at the end of the procedure. Blood samples were taken at 5, 15, 30 and 60 min after insertion and lidocaine concentrations were measured using high-performance liquid chromatography.
RESULTS: Mean (range) plasma lidocaine concentrations at 5, 15, 30 and 60 min were 40.3 (0-221.9), 66.3 (0-271.9), 64.9 (0-208) and 75 (0-212) ng ml(-1), respectively.
CONCLUSION: There was minimal systemic absorption of lidocaine from the uterus following uterine balloon thermal ablation. Measured concentrations were well below the toxic plasma concentration for lidocaine (8-10 micro g ml(-1)).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453927     DOI: 10.1093/bja/aef267

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  2 in total

1.  TASK Channel Deletion Reduces Sensitivity to Local Anesthetic-induced Seizures.

Authors:  Guizhi Du; Xiangdong Chen; Marko S Todorovic; Shaofang Shu; Jaideep Kapur; Douglas A Bayliss
Journal:  Anesthesiology       Date:  2011-11       Impact factor: 7.892

Review 2.  Intrauterine anesthesia for gynecologic procedures: a systematic review.

Authors:  Rebecca J Mercier; Matthew L Zerden
Journal:  Obstet Gynecol       Date:  2012-09       Impact factor: 7.661

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.